Andere talen Zenith Capital Corporation

Aandelen

ZENI.P

CA98936P1071

Vertraagde tijd Toronto S.E. Andere beurzen 17:00:00 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,105 ^CAD	-.--%		-.--%	-.--%

28/03	Zenith Capital Corporation rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 januari 2024	CI
2023	Zenith Capital Corporation rapporteert resultaten voor het gehele jaar dat eindigde op 31 juli 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	28/03
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2023	27/11
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	14-06-23
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	28-03-23
Grand Samsara Consulting LLC and CBGB Ventures Corp. signed a binding letter agreement to acquire Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction.	20-03-23
IIROC Trading Halt - ZENI.P	09-03-23
Zenith Capital Corporation announced that it expects to receive CAD 1 million in funding from Grand Samsara Consulting LLC	08-03-23
Zenith Capital Corporation announced that it has received CAD 0.2 million in funding	23-02-23
Zenith Capital Corporation announced that it expects to receive CAD 0.2 million in funding	15-02-23
IIROC Trading Resumption - ZENI.P	07-02-23
Venda Robotix Ltd cancelled the acquisition of Zenith Capital Corporation (TSXV:ZENI.P) in a reverse merger transaction..	23-01-23
Zenith Capital Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	08-12-22
Zenith Capital Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	16-11-22
IIROC Trading Halt - ZENI.P	08-09-22
Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials	07-07-22
ZENITH CAPITAL CORPORATION PROVIDES UPDATE TO PREVIOUSLY ANNOUNCED QUALIFYING TRANSACTION WITH VENDA ROBOTIX	01-07-22
Zenith Epigenetics Triple Negative Breast Cancer Clinical Data Highlighted in an Oral Discussion at the American Society of Clinical Oncology Conference (ASCO)	22-06-22
Zenith Capital Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	21-06-22
Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer Clinical Trial	11-05-22
Zenith Capital Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	28-03-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zenith Capital Corporation

Aandelen

ZENI.P

CA98936P1071

Andere talen

Filters